- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Going Below the Surface of Healthcare Cost Discussions With Dr Bobby Dubois
In an effort to get to the root of healthcare spending in the United States, the National Pharmaceutical Council launched the Going Below the Surface initiative.
In an effort to get to the root of healthcare spending in the United States, the National Pharmaceutical Council launched the Going Below the Surface initiative. In addition to examining the drivers of healthcare spending, the initiative is creating a national multistakeholder dialogue to determine best practices for optimizing spending.
Today, we speak with Bobby Dubois, MD, PhD, chief science officer and executive vice president, National Pharmaceutical Council, about the initiative, its goals, and what it has found so far.
To listen to the podcast, please login.
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Listen above or or through one of these podcast services:
Learn more about drug prices in the United States and efforts to lower them:
From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs
Healthcare Spending Driven by Price, Not Utilization: JAMA Study
A Look at the Legal and Legislative Landscape Impacting Drug Costs for Patients
October 23rd 2024Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy benefit managers and cost-shifting programs.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Dr John M. O'Brien Highlights Critical Role of Rebates in Employer Benefit Choices
August 5th 2024John M. O'Brien, PharmD, MPH, of the National Pharmaceutical Council, discusses his recent study, which sheds light on how important rebates are when choosing benefits for employers and who advises employers on these choices.
Read More
Prescription Rebate Guarantees: Employer Insights
July 19th 2024This study examined employers’ understanding of rebate guarantees, dependency upon rebate dollars, and the role that pharmaceutical rebates or employer benefits consultants play in their pharmacy benefits manager selection.
Read More
